Senior insider sale
Chief Executive Officer at CORCEPT THERAPEUTICS INC — senior position signals high conviction
$4.21M
79.03K shares
What this filing means
BELANOFF JOSEPH K plans to sell 79.03K shares of CORCEPT THERAPEUTICS INC valued at approximately $4.21M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/1/2026ACC: 0001973251-26-000018
DirectorOfficer· Chief Executive Officer
Since Feb 2026
79.03K
Shares to sell
$4.21M
Approx. market value
12.84K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
7/6/2022
12.84KTotal acquired12.84K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/6/2022 | Stock Option Exercise Cash | 12.84K | — |
| Total | 12.84K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
40K
Market value
$2.00M
5/1/2026
—Completed
Units to sell
26.20K
Market value
$1.31M
3/25/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
12.84K
Market value
$892.0K
6/1/2026
Total
Units
79.03K
Value
$4.21M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/1/2026 | 40K | $2.00M | — | Completed |
3/25/2026 | 26.20K | $1.31M | — | Completed |
| Planned — Approximate Date | ||||
6/1/2026 | 12.84K | $892.0K | NASDAQ | Planned |
| Total | 79.03K | $4.21M | ||